These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26229)

  • 1. [Scleroderma, an ageing process? I. Clinical and immunological aspects (author's transl)].
    Sandhofer M; Fritz J; Altmann H
    Aktuelle Gerontol; 1977 Dec; 7(12):645-51. PubMed ID: 26229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of skin scleroderma--literature review].
    Wojas-Pelc A; Lipko-Godlewska S
    Przegl Lek; 2005; 62(5):310-3. PubMed ID: 16334538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cellular immune phenomenon in scleroderma].
    Fritz J; Sandhofer M
    Dermatologica; 1977; 154(3):129-37. PubMed ID: 852625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scleroderma].
    Scharffetter K; Kind P; Wollny-Protzel D; Schuppe HC; Lakomek HJ; Goerz G
    Z Hautkr; 1990 Mar; 65(3):237-42, 245-6. PubMed ID: 2187309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 6. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 7. [Scleroderma in children (author's transl)].
    Posternak F; Orusco M
    Schweiz Rundsch Med Prax; 1974 Jul; 63(30):913-21. PubMed ID: 4547092
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopathogenesis of scleroderma--evolving concepts.
    Sapadin AN; Esser AC; Fleischmajer R
    Mt Sinai J Med; 2001; 68(4-5):233-42. PubMed ID: 11514910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Respiratory function profile in scleroderma. 20 cases (author's transl)].
    Kleisbauer JP; Feliciano JM; Colonna J; Velardocchio JM; Laval P
    Poumon Coeur; 1980; 36(6):371-6. PubMed ID: 7220421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cellular immune response to collagen I in patients with systemic scleroderma].
    Vladimirtsev VA; Avdeeva ZhI; Guseva NG; Rassokhina II; Anan'eva LP
    Vopr Revm; 1982; (1):33-8. PubMed ID: 6178214
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cellular immunity in systemic scleroderma (author's transl)].
    Hattori A
    Nihon Hifuka Gakkai Zasshi; 1978 Apr; 88(5):347-58. PubMed ID: 149207
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiopathology of scleroderma].
    Fleischmajer R; Perlish JS; Maquart FX; Kalis B
    Ann Dermatol Venereol; 1993; 120(2):157-66. PubMed ID: 8363310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Connective tissue disease in India. III. Clinical and immunological profile of progressive systemic sclerosis.
    Malaviya AN; Adhar GC; Pasricha JS
    J Assoc Physicians India; 1979 May; 27(5):395-400. PubMed ID: 316815
    [No Abstract]   [Full Text] [Related]  

  • 16. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis].
    Gustafsson R
    Nord Med; 1994; 109(8-9):236-7. PubMed ID: 7937033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of scleroderma: an update.
    Haustein UF; Anderegg U
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):1-8. PubMed ID: 9731958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Increased retraction of collagen lattices by fibroblasts from patients with scleroderma].
    Gillery P; Maquart FX; Kalis B; Borel JP
    C R Acad Sci III; 1986; 303(3):59-64. PubMed ID: 3093006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phoniatric and laryngological aspects of systemic scleroderma (author's transl)].
    Sopko J; Wey W
    HNO; 1978 Feb; 26(2):65-7. PubMed ID: 632135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.